Acute Liver Failure Diagnostic Criteria
Acute liver failure (ALF) is diagnosed when a patient without preexisting liver disease develops coagulopathy (INR ≥1.5) and any degree of hepatic encephalopathy, typically within 26 weeks of symptom onset. This represents the most widely accepted definition across major guidelines 1, 2.
Core Diagnostic Components
The essential elements required for ALF diagnosis are:
- No known chronic liver disease prior to presentation
- Coagulopathy: INR ≥1.5 (some criteria use INR ≥2.0 or prothrombin time ≤40% of normal) 3, 4
- Hepatic encephalopathy: Any grade of altered mentation attributable to liver dysfunction 1, 2
- Acute onset: Symptoms developing within 26 weeks, though most cases evolve over days to weeks 4, 5
- Elevated aminotransferases: Rapid-onset elevation of AST/ALT 4
Important Distinctions
ALF vs. Acute-on-Chronic Liver Failure (ACLF)
ACLF must be distinguished from ALF because it occurs in patients with underlying chronic liver disease or cirrhosis 6. ACLF requires:
- Acute onset with rapid clinical deterioration
- Liver failure (elevated bilirubin AND elevated INR) in patients with chronic liver disease/cirrhosis
- At least one extrahepatic organ failure (neurologic, circulatory, respiratory, or renal) 6
The presence of preexisting cirrhosis automatically excludes pure ALF and shifts the diagnosis to ACLF 6, 4.
Severity Classification Within ALF
Once ALF is diagnosed, further stratification by timing of encephalopathy development helps predict prognosis:
- Hyperacute: Encephalopathy within 7 days of jaundice onset
- Acute: Encephalopathy 8-28 days after jaundice
- Subacute: Encephalopathy 29 days to 26 weeks after jaundice 3, 7
Special Considerations
Autoimmune Hepatitis-Related ALF
In the context of autoimmune hepatitis (AIH), specific criteria apply 8:
- Acute severe AIH (AS-AIH): Jaundice + coagulopathy (INR >1.5) without encephalopathy
- AIH-ALF: When encephalopathy is also present in addition to jaundice and coagulopathy
The presence of encephalopathy in AS-AIH immediately reclassifies the condition as AIH-ALF and should trigger urgent liver transplant evaluation 8. This distinction is critical because AIH-ALF has significantly worse outcomes (only 9-32% recovery) compared to AS-AIH (two-thirds survive with corticosteroids) 8.
Pediatric ALF
Pediatric criteria differ slightly 9:
- No known chronic liver disease
- Liver-based coagulopathy unresponsive to parenteral vitamin K
- INR 1.5-1.9 with clinical encephalopathy, OR
- INR ≥2.0 regardless of encephalopathy presence
Common Pitfalls
Missing underlying cirrhosis: Always exclude preexisting chronic liver disease through history, imaging, and laboratory assessment. Unrecognized cirrhosis changes the diagnosis to ACLF, which has different management implications 6, 4.
Waiting for high-grade encephalopathy: Any degree of altered mentation counts. Grade I encephalopathy (subtle changes in attention, sleep disturbance) is sufficient for ALF diagnosis 1, 2.
Overlooking the time window: Symptoms developing beyond 26 weeks suggest chronic liver disease rather than ALF 4, 5.
Confusing ACLF with ALF: The key differentiator is whether chronic liver disease existed before the acute event. ACLF patients have underlying cirrhosis; ALF patients do not 6, 4.
Diagnostic Workup Requirements
Once ALF is suspected, mandatory testing includes 1, 2:
- Comprehensive medication history: All prescription drugs, herbals, dietary supplements, and recreational substances
- Viral serologies: Hepatitis A, B, C, E; HSV; EBV; CMV
- Autoantibody testing: ANA, ASMA, anti-LKM1 (even if IgG is normal, as 25-39% of acute AIH patients have normal IgG) 8, 1
- Toxicology screen: Acetaminophen level (most common cause in Western countries)
- Metabolic workup: Ceruloplasmin, 24-hour urine copper (Wilson's disease)
- Pregnancy test: In women of childbearing age
Liver biopsy is NOT routinely recommended due to bleeding risk in coagulopathic patients and limited impact on management decisions 1.